We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Rapid POC Salivary Diagnostic Technology Shows Potential for Detecting Various Disease Biomarkers

By LabMedica International staff writers
Posted on 15 May 2023

Across the globe, approximately 3. More...

5 billion individuals are currently afflicted by oral diseases. Numerous oral bacteria are also associated with systemic illnesses such as diabetes, heart disease, and cancer. Now, a new diagnostic tool that can be used in a dental office analyzes saliva samples to provide comprehensive information on oral health and determine the risk for cavities and gum disease and systemic diseases.

Scientists from the Forsyth Institute (Cambridge, MA, USA) have demonstrated a CRISPR-based technology that can identify specific oral pathogens in approximately half an hour. The SHERLOCK system, a CRISPR-Cas molecular diagnostic platform, can accurately pinpoint and target RNA and DNA molecules in a sequence-specific manner. This technology has been tailored to target four oral bacteria known to contribute to oral health issues, such as periodontitis (gum disease) and dental cavities. The new point-of-care diagnostic technology could revolutionize dental care and facilitate early disease detection, eliminating the discomfort, inconvenience, and expense of blood tests.

In the recent study, the researchers tested the system on three bacteria associated with a variety of conditions, including cancer, digestive diseases, cardiovascular diseases, and neurodegenerative diseases. The findings indicated the impressive adaptability of the diagnostic tool to identify any biomarker from saliva, including markers related to inflammation and cancer. Using this innovative detection method, a person could simply provide a saliva sample and receive highly precise results in a minimal amount of time. This test could be administered in a dental clinic without the need for specialized skills.

“Targeted treatments are only possible when you know which bugs are in the mouth. In any disease, we cannot begin to create effective treatments until we have diagnostics,” said Dr. Batbileg Bor, who led the study and is an Assistant Member of Staff at Forsyth. “Currently, available tests on the market are either low sensitivity or require analysis at an expensive centralized laboratory. It can take months to get the results. The studied detection tool solves both problems, featuring high-sensitivity, low-cost tests with rapid results.”

“The test is so sensitive it can detect as little as 10s of bacteria cells of a certain type from a sample that might contain around 200 species of bacteria commonly found in your mouth,” added Dr. Bor. “We were able to target and detect specific bacteria in unprocessed saliva, meaning we could get this level of sensitivity and specificity without having to additionally process the saliva sample.”

Related Links:
Forsyth Institute 


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The LIAISON NES Group A Strep assay is intended for use on the LIAISON NES POC molecular diagnostics system (Photo courtesy of Diasorin)

Group A Strep Molecular Test Delivers Definitive Results at POC in 15 Minutes

Strep throat is a bacterial infection caused by Group A Streptococcus (GAS). It is a leading bacterial cause of acute pharyngitis, particularly in children and adolescents, and one of the most common reasons... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Pathology

view channel
Image: Sophie Paczesny, M.D., Ph.D and her team have made BIOPREVENT freely available for researchers and clinician to test and learn from (Photo courtesy of Cliff Rhodes)

AI Tool Uses Blood Biomarkers to Predict Transplant Complications Before Symptoms Appear

Stem cell and bone marrow transplants can be lifesaving, but serious complications may arise months after patients leave the hospital. One of the most dangerous is chronic graft-versus-host disease, in... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.